What question did this study set out to answer?

To evaluate the efficacy and safety of telitacicept in treating glomerulonephritis, particularly in elderly patients.

March 28, 2026Open Access

WCN26-3658 Efficacy and Safety of Telitacicept in the Treatment of 10 Patients with Glomerulonephritis

Key Points

To evaluate the efficacy and safety of telitacicept in treating glomerulonephritis, particularly in elderly patients.
Assessment of 10 patients with glomerulonephritis
Evaluation of treatment outcomes using telitacicept
Emphasis on individualized therapeutic strategies
Findings indicate positive treatment responses
Risk management considerations are important for elderly patients
No major safety concerns reported

Abstract

elderly patients.These findings underscore the need for individualized therapeutic strategies and careful risk management in elderly LN.I have no potential conflict of interest to disclose.I used generative AI and AI-assisted technologies in the writing process.During the preparation of this work, the authors used ChatGPT/ OpenAI for English language editing.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Hongli Zhou

Journals

Kidney International Reports

Actions

Institutions

58.com (China)

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

WCN26-3658 Efficacy and Safety of Telitacicept in the Treatment of 10 Patients with Glomerulonephritis

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider